A license is required in all instances where our industry partners wish to use HUB’s proprietary Organoid Technology in-house. HUB Organoid Technology represents a breakthrough in the field of stem cell research and it is based on extensive knowledge of the underlying biology of adult stem cells.

We offer license packages to companies that pursue the technology for developing therapeutics, or manufacturing and selling organoid-related products.

get started

License packages

Drug Development

Biobanking

Equipment Validation

Seamlessly integrate organoid technology into your drug screening and development platform

Generate your own patient-derived organoid biobank for distribution to third parties

Validate the suitability of your equipment for organoid use

  • Starts from 5 years
  • Upfront fee
  • Annual fee
  • Payment per clinical success milestone
  • Starts from 5 years
  • Upfront fee
  • Royalty fee
  • Starts from 5 years
  • Upfront fee
  • Annual fee

get a quote

get a quote

get a quote

Features Drug development Biobanking Equipment validation
Generate your own patient-derived organoids from patient tissue
Optimized protocols for establishing, passaging and maintaining organoid cultures
Access to HUB’s validated list of reagents
End-to-end tech transfer support
Use PDOs purchased from approved vendors
Standardized protocol for organoid screening

talk to sales

talk to sales

talk to sales

Core of HUB’s patent portfolio

HUB Organoid Technology is covered by an extensive and broad IP. As the inventor of HUB Organoid Technology, our extended IP portfolio covers all aspects of Organoid Technology and is based on 4 knowledge pillars:

  • Product: adult stem cell-derived organoids from both human and animal epithelium
  • Media composition: tailored organ-specific culture compositions
  • Application: use of organoid technology in any field, i.e. from drug discovery/development, diagnostics, to regenerative medicine
  • Methodology: optimized protocols for establishment, expansion, and differentiation

Tech transfer packages

Our tech transfer packages are an essential part of HUB licensing, providing you the unique opportunity to get in touch with our experts and benefit from their extensive experience to implement HUB Organoid Technology in the most successful and efficient way.

Basic Advanced best for beginnersExtended
Get started with organoid technology Everything you need to incorporate our technology in-house Deploy the full potential of organoid technology
Validity 3 months 4 months 5 months
Number of sessions 3 4 5
End-to-end tech transfer support
Help center & Email support

talk to sales

talk to sales

talk to sales

Empowering innovation through

hands-on training

New to HUB Organoid Technology? Want to upskill your research team on how to establish, maintain and make the most of patient-derived organoid technology? We offer in-person training to our licensees at HUB’s premises to help you get started.

Gain hands-on expertise from our scientists on-site

talk to sales

NEWS AND INSIGHTS

Mimetas expands adult stem cell organoid license to all organs

read more

FACTSHEET

Discover our unique license service offering

download now

BLOG

Do you need a license to work with HUB Organoid Technology?

read more

X

Have any questions?

contact us
PRESS RELEASE

Merck to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio

learn more

Powered by